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Abstract
Introduction
Patients with tuberculosis (TB) symptoms have high prevalence of HIV, and should be priori-
tised for HIV testing.
Methods
In a prospective cohort study in Bangwe primary care clinic, Blantyre, Malawi, all adults (18
years or older) presenting with an acute illness were screened for TB symptoms (cough,
fever, night sweats, weight loss). Demographic characteristics were linked to exit interview
by fingerprint bioidentification. Multivariable logistic regression models were constructed to
estimate the proportion completing same-visit HIV testing, comparing between those with
and without TB symptoms.
Results
There were 5427 adult attendees between 21/5/2018 and 6/9/2018. Exit interviews were
performed for 2402 (44%). 276 patients were excluded from the analysis, being already on
antiretroviral therapy (ART). Presentation with any TB symptom was common for men
(54.6%) and women (57.4%). Overall 27.6% (585/ 2121) attenders reported being offered
testing and 21.5% (455/2121) completed provider-initiated HIV testing and counselling
(PITC) and received results. The proportions offered testing were similar among participants
with and without TB symptoms (any TB symptom: 29.0% vs. 25.7%). This was consistent
for each individual symptom; cough, weight loss, fever and night sweats. Multivariable
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regression models indicated men, younger adults and participants who had previously
tested were more likely to complete PITC than women, older adults and those who had
never previously tested.
Conclusions
Same-visit completion of HIV testing was suboptimal, especially among groups known to
have high prevalence of undiagnosed HIV. As countries approach universal coverage of
ART, identifying and prioritising currently underserved groups for HIV testing will be
essential.
Introduction
The deadline of the Joint United Nations Programme 90-90-90 campaign to end the HIV epi-
demic by 2020 is approaching.[1] Substantial global progress has been made with seven coun-
tries having reached the target of achieving high coverage of viral suppression amongst all
people living with HIV.[2] Malawi is among the large proportion of countries still striving to
reach these targets.
Through initiatives such as provider-initiated testing and counselling (PITC), and with the
strong support of the Malawi National HIV Programme, 70% of Malawians knew their status
in 2016.[2] Despite this being an improvement on previous years, there remains substantial
room for further improvement.
Current Malawian National Guidelines focus on facility testing and community testing as
priority opportunities for HIV testing and diagnosis.[3] PITC is recommended for anyone
attending healthcare facilities including outpatient departments as one of the most effective
strategies for identifying new HIV diagnoses. Other strategies recommended include index
testing and self-testing. [3] Community-based HIV testing strategies have helped to reach the
“untested” population, including key populations with high HIV prevalence that are hard to
reach, such as men who have sex with men, female sex workers, people who inject drugs, and
transgender women.[4] Despite impressive achievements in increasing community-based
strategies, the majority of HIV testing still occurs in health facilities. PITC in health facilities
remains a critical strategy for identifying and linking to care people with advanced HIV and
concomitant high risk of death. When investigated previously in Blantyre, Malawi in 2011
only 13% of all adult clinic attenders completed PITC, leading to many missed opportunities
for diagnosis and linkage to ART.[5]
New strategies for improving rates of HIV test offer within health facilities are essential to
help reach the untested population. One strategy is routine opt-out (ROOT) HIV testing in
which patients are offered an HIV test at each clinic visit unless they specifically refuse.[6] A
further is utilising semi-supervised oral fluid based HIV testing kits within facilities.[7]
Patients presenting with symptoms of tuberculosis (TB)–cough (of any duration), fever,
weight loss and night sweats–have a high prevalence of undiagnosed HIV and advanced
immunosuppression.[8] In fact, in settings with generalised HIV epidemics those presenting
with TB symptoms have higher prevalence of HIV than people with confirmed TB.[9] Despite
the high HIV prevalence in patients with TB symptoms, they are not listed as a priority screen-
ing group in the Malawian National Strategic Plan for HIV and AIDS.[10]
This study investigated PITC uptake for those with and without TB symptoms at a busy pri-
mary health care centre in Malawi. The objectives were to describe the fraction of acute adult
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clinic attenders who were offered and received HIV testing and counselling, and to explore
risk factors associated with non-completion of PITC.
Methods
Study design and participants
We undertook a prospective study among adults (18 years or older) attending Bangwe Health
Centre (BHC) with an acute illness between 21st May 2018 and 6th September 2018. BHC is a
busy public primary health care clinic located in urban Blantyre, Malawi, where adult HIV
prevalence is 18%[11] and TB prevalence approximately 1%.[12] This study was nested within
the pilot phase of a pragmatic randomised trial being conducted at the clinic that aims to eval-
uate strategies to optimise diagnosis and treatment initiation for HIV and tuberculosis. [13]
BHC has an adult outpatient department where community members can self-present and
are registered and receive care free-of-charge for illnesses. Within BHC, there are additionally
HIV, TB, antenatal, and paediatrics departments from where we did not recruit study partici-
pants. At BHC there are no physicians; medical care is provided by nurses and clinical officers.
PITC is recommended by the Malawi National HIV Programme for all attendances to an out-
patient department, and was available at BHC, provided by Ministry of Health-accredited
counsellors. ART and antituberculosis therapy were provided onsite at the HIV care clinic and
TB clinic respectively. Sputum smear microscopy and GeneXpert MTB/Rif testing were avail-
able onsite in the clinic laboratory. Patients requiring chest X-ray for investigation of possible
TB required healthcare referral to the city’s central hospital.
Screening and exit interviews
Research assistants stationed at the clinic’s outpatient department registration desk identified
all adult individuals attending the clinic to receive acute care. Following verbal consent, a fin-
gerprint scan was recorded for bioidentification. Research assistants then undertook a brief
screen, recording clinic attenders’ age, sex and the presence of TB symptoms (cough and
cough duration, fever, weight loss, and night sweats). Information was not recorded from par-
ticipants who declined fingerprint scanning. Following the completion of screening, clinic
attenders joined the outpatient department queue to be seen by health workers.
Next, participants were reviewed by a health worker. Health workers worked independently
from research assistants and were unaware of the results of questions asked during initial
screening. Health workers were not required to screen for TB symptoms as part of study proto-
col, however it is recommended in national and WHO guidelines that all clinic attenders be: 1)
Screened for TB symptoms and 2) Offered PITC.[14]
Research assistants were also based at the two clinic outpatient department exits, where
they identified adults leaving the department and invited them to participate in an exit inter-
view. The layout of the clinic is such that all participants exiting the clinic would pass the
research assistants. Though researchers tried to select as many patients as possible, due to limi-
tations in the number of research assistants not all participants completed exit interview. To
minimise inconvenience and maximise research assistants’ capacity to complete interviews,
questionnaires were brief with predominantly binary responses to questions rather than in-
depth qualitative questions. Prior to exit interview identity was verified by fingerprint bioiden-
tification. Clinic attenders were asked about the care they received whilst in the clinic, includ-
ing whether they had been offered HIV testing, and whether HIV testing had been completed
during their clinic visit. We additionally recorded whether participants had ever previously
tested for HIV, their self-reported HIV and ART status, and whether they had previously been
treated for TB.
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Statistical methods
We summarised characteristics of clinic attenders using proportions, medians and means, and
compared them between those who did and did not undergo clinic exit interview. Individuals
who reported cough of any duration, fever, weight loss, or night sweats were classified as hav-
ing “any TB symptom”. Cough duration was also recorded and in accordance with WHO
guidelines, we defined chronic cough as self-reported cough lasting greater than two weeks.
Participants with known HIV-positive status who were already taking ART were excluded
from the analysis. Those with self-reported HIV positive status who were not taking ART were
included as this provides further opportunity for confirmatory testing and linkage to ART. We
summarised the proportion of clinic attenders who reported having been offered an HIV test
and who reported having completed an HIV test on the same day as their visit, and compared
groups by demographic and clinical characteristics. As previous research suggests men have a
higher burden of undiagnosed TB and present later for diagnoses than women, results were
stratified by sex to investigate differences between sexes. [8]
To investigate characteristics associated with reporting completing HIV testing during a
clinic visit exit interview, we constructed Bayesian multivariable logistic regression models.
[15] Initial models included terms for age and sex, and subsequent models evaluated the incre-
mental improvement in model fit from adding reported history of previous TB treatment and
having previously tested for HIV. We then constructed models including terms for the pres-
ence of either: cough; chronic cough; or any TB symptoms. Weakly regularising priors were
applied to model intercepts and slopes. Convergence was evaluated by inspecting trace plots
and effective sample numbers, and by calculating Gelman-Rubin statistics. Model fits were
compared using the Watanabe-Akaike information criteria (WAIC) statistic and weights.
Three thousand samples were drawn from each model posterior distribution using Markov
Chain Monte Carlo methods implemented within Stan. Model coefficients on the log-odds
scale were exponentiated to give odds ratios, and posterior means and 89% probability inter-
vals were calculated and plotted. Posterior predictions for age and sex were graphed, stratified
by presence of TB symptoms (cough, chronic cough, any TB symptom). Analysis was con-
ducted using R version 3.5.2 (R Foundation for Statistical Computing, Vienna).
Ethical approval
Ethical approval was received from the College of Malawi Research Ethics Committee (COM-
REC), and from the Liverpool School of Tropical Medicine Research Ethics Committee. Indi-
viduals undergoing exit interviews provided written (or witnessed thumb-print if illiterate)
consent.
Data and reproducibility
Data and code to reproduce these analyses are available as an R package from https://github.
com/petermacp/hiv.prospect.
Results
Characteristics of clinic attenders
Between 21st May and 6th September 2018, a total of 5427 adult acute attendances were
recorded at the study clinic. Five individuals declined fingerprint identification and were not
included in the study. Of the remaining 5422 attendances, 4895 (90%) were by individuals
who attended the clinic only once during the study period, and 527 (10%) by individuals who
attended more than once; the maximum number of clinic attendances during the study period
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was seven, recorded by one individual. The number of daily acute clinic attendances recorded
ranged between 41 and 106 (mean = 70.4, median = 69).
Overall, 64% (3486/5422) of clinic attendance episodes were by women, with similar age
distributions between women (median: 28 years, range: 18–88) and men (median: 28 years,
range: 18–89)–Table 1. Women and men attending the clinic had similar distributions of
reported: cough of any duration (women: 1135, 33%; men: 686, 35%); chronic cough (women:
218, 11.3%; men: 304, 8.7%); weight loss (women: 431, 12.4%; men: 281, 14.5%); fever
(women: 951, 27.3%; men: 630, 32.5%); night sweats (women: 596, 17.1%; men: 388: 20.0%);
and any TB symptom (women: 1905 (54.6%; men: 1111 (57.4%). Overall, 1.4% (77/5422) of
clinic attenders reported being currently treated for TB (women: 48, 1.4%; men: 29, 1.5%).
A total of 2397 (44%) clinic attendances were followed by same-day study exit interviews.
Characteristics between clinic attenders who did and did not complete exit interviews were
similar, but with some differences (Table 1). Women (1497, 42.9%) were less likely to complete
exit interviews than men (900, 46.5%). Additionally, clinic attenders who reported any TB
symptom were more likely to complete an exit interview compared to clinic attenders who
didn’t (45.4% vs 42.7%). This was consistent for cough, fever, weight loss and night sweats.
However those with chronic cough were less likely to complete exit interview than those with-
out (42.3% vs 44.4%).A total of 276 (11.5%) clinic attenders reported that they were HIV posi-
tive and taking ART and were exclude from regression modelling.
Table 1. Characteristics of adult acute clinic attendances.
Exit Interviewed (N = 2397) Not Exit Interviewed (N = 3025) Total (N = 5422)
Sex
Female 1497 (42.9%) 1989 (57.1%) 3486 (100.0%)
Male 900 (46.5%) 1036 (53.5%) 1936 (100.0%)
Age
Median (Range) 28 (18, 89) 27 (18, 89) 28 (18, 89)
Cough
No 1548 (43.0%) 2053 (57.0%) 3601 (100.0%)
Yes 849 (46.6%) 972 (53.4%) 1821 (100.0%)
Weight Loss
No 2081 (44.2%) 2629 (55.8%) 4710 (100.0%)
Yes 316 (44.4%) 396 (55.6%) 712 (100.0%)
Fever
No 1663 (43.3%) 2178 (56.7%) 3841 (100.0%)
Yes 734 (46.4%) 847 (53.6%) 1581 (100.0%)
Night Sweats
No 1936 (43.6%) 2502 (56.4%) 4438 (100.0%)
Yes 461 (46.8%) 523 (53.2%) 984 (100.0%)
Any TB Symptom†
No 1027 (42.7%) 1379 (57.3%) 2406 (100.0%)
Yes 1370 (45.4%) 1646 (54.6%) 3016 (100.0%)
Chronic Cough¶
No 2176 (44.4%) 2724 (55.6%) 4900 (100.0%)
Yes 221 (42.3%) 301 (57.7%) 522 (100.0%)
† Any TB symptom: cough, or weight loss, or fever, or weight loss.
¶ Cough of 14 days or longer
https://doi.org/10.1371/journal.pone.0236407.t001
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Of 2121 patients included in the analysis 1907 (89.9%) self-reported previously ever testing
for HIV, in comparison to 214 (10.1%) who self-reported never testing. Females (1194/1295,
92.2%) were more likely to self-report previous HIV testing than males (713/826, 86.3%). Pre-
vious testers (median: 27 years, range 18–87), were of similar age to non-testers (mean: 26
years, range 18–89).
Offer and completion of HIV testing
A total of 585/2121 (27.6%) eligible participants reported being offered HIV testing by a health
worker during their clinic attendance, and 455/2121 (21.5%) completed HIV testing. Twenty-
nine percent of men (242/826) and twenty-six percent (343/1295) of women were offered HIV
testing by health workers. Those offered HIV testing were younger than those not (median
age: 26 vs. 29 years respectively). There were few differences in the proportions offered HIV
testing among participants who reported and did not report TB symptoms (any TB symptom:
348/1199, 29.0% vs. 237/922, 25.7%; cough: 211/732, 28.8% vs. 374/1389, 26.9%; chronic
cough: 39/179, 21.7% vs. 546/1942, 28.1%; weight loss: 74/252, 29.3% vs. 511/1869, 27.3%;
fever: 190/647, 29.3% vs. 395/1474, 26.8%; night sweats: 104/407, 25.6% vs. 481/1714, 28.1%).
Participants who reported previously having been treated for TB were less likely to be offered
HIV testing (16/78, 20.5%) than those not previously treated for TB (569/2043, 27.9%). Partici-
pants who self-reported previously testing for HIV were more likely to be offered testing (539/
1907, 28.3%), than those who had not previously HIV tested (46/214, 21.5%).
In addition to being more likely to be offered HIV testing, men (184/242, 76.0%) were
more likely to report completing HIV testing compared to women (252/343, 73.4%). Age was
also associated with completion of HIV testing, with the median age of those completing test-
ing (26 years) lower than those who didn’t complete HIV testing (29 years). Similarly, patterns
of completion of HIV testing among those with and without TB symptoms closely mapped
data for offer of HIV testing (cough: 165/211, 78.2% vs. 271/374, 72.5%; chronic cough: 28/39,
71.8% vs. 408/546, 74.7%; weight loss: 54/74, 73.0% vs. 382/511, 74.8%; fever: 135/190, 71.1%
vs. 301/395, 76.2%; night sweats: 74/104, 71.2%% vs. 362/481, 75.3%; any TB symptom: 254/
348, 73.0% vs. 182/237, 76.8%). Participants who had previously been treated for TB (9/16,
56.25%) were less likely to complete HIV testing than those hadn’t previously been treated
(427/659, 75.0%). Participants who self-reported previous HIV testing were likelier to complet-
ing testing (417/539, 77.4%) than those who had not (19/46, 41.3%).—(Fig 1).
In the initial regression model (Table 2, Model 1), men were more likely to complete HIV
testing than women (posterior odds ratio: 1.15, 89% interval: 0.97–1.37), and older participants
were less likely to complete HIV testing (posterior odds ratio per year increase in age: 0.99,
89% interval: 0.98–0.99). Models that included terms for cough (Models 2a, 2b and 2c) addi-
tionally showed that reporting cough, and having previously tested for HIV increased the pos-
terior odds of HIV testing, whilst previously being treated for TB decreased the posterior odds
of completing HIV testing. In contrast, having chronic cough instead of cough (Models 3a, 3b,
3c) resulted in a reduced posterior odds ratio of completing HIV testing. Reporting any TB
symptom (Models 4a, 4b and 4c) was linked to a reduced posterior odds ratio for completing
HIV testing. Models that included terms for age, sex, previous HIV testing, previous TB treat-
ment, and either cough, chronic cough or any TB symptom (Models 2c, 3c and 4c) had the
lowest WAIC statistics and greatest weight. Model summary estimates are provided in Table 2
and visually in Fig 2.
When converted to the probability scale, there was strong evidence of decreased probability
of completing HIV testing with increasing age across all three models that included terms for
TB symptoms (Models 2c, 3c and 4c). Additionally, the posterior probability of HIV testing
PLOS ONE Provider-initiated HIV testing and TB screening in the era of universal coverage in Blantyre, Malawi
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was consistently higher among men than women, as well as those with a prior self-reported
history of HIV testing. (Fig 3).
Discussion
The findings of our study reveal that less than one-third (27.6%) of adults attending a primary
health care clinic with an acute care episode were offered an HIV test, and only 21.4% com-
pleted same-day HIV testing. Despite this being an improvement on when previously exam-
ined in Blantyre in 2010 (13%), [5] this study reveals many missed opportunities for HIV
testing and diagnosis. This highlights lack of implementation of national guidelines, which
state that all patients attending an outpatient appointment should be offered an HIV test.
A recent overview of delivery of facility-based HIV testing services in Malawi showed that
the majority of health centres use symptom-based PITC, with more unwell people prioritised
for HIV testing.[16] Understanding the rationale for this and developing new strategies are
key for further improvement. Previous qualitative research has revealed that health care work-
ers felt more compelled to provide PITC in ANC than in outpatients departments.[17] Health-
care workers also saw ART as a precious resource which should be reserved for those who
were more unwell in outpatient departments. Utilising symptom-based PITC leads to
Fig 1. Percentages of participants offered and completing HIV testing by TB symptoms. Proportions of patients offered HIV testing.
Stratified by those with TB symptoms (top row) and those without TB symptoms (bottom row).
https://doi.org/10.1371/journal.pone.0236407.g001
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detection of patients later in their disease course with greater risk of suboptimal HIV treatment
outcomes. Moreover, certain groups who are difficult to reach through existing programmes
and who have higher rates of undiagnosed HIV (such as older people) are disadvantaged.
Changes in approach are needed to reduce further missed opportunities for testing. One
strategy would be to include a ROOT approach in national guidelines whereby patients are
offered an HIV test for every acute care attendance unless they decline, potentially leading to
higher uptake of HIV testing. [6] Using the ROOT approach is resource intensive and com-
mon barriers to reaching 100% coverage include limited health worker capacity, inadequate
space in facilities, and insufficient test kits.[5,16] These stated limitations may account for the
population of patients in our study who were offered HIV testing but did not undergo a test.
A second approach would be utilising semi-supervised oral fluid-based rapid HIV self-test-
ing kits within facilities to help overcome some of these barriers. This has previously been
implemented with success in a rural African setting with high rates of accuracy and user accep-
tance.[7] Qualitative research has suggested that patients who noticed a decline in their health,
may wish to know their status and therefore may be motivated to test themselves.[17] This
strategy may be key to removing the heavy burden of work on the healthcare workers and
empowering patients to know their own status.
In generalised HIV epidemics, people with symptoms of TB have a high prevalence of HIV
at all levels of healthcare; including community level, primary health care and hospital inpa-
tients.[9] In acknowledgement of these patients being a high risk group, WHO policy on col-
laborative TB/HIV activities was updated in 2012 to advise that in generalised HIV epidemics
routine HIV testing should be offered to all with presumptive or diagnosed TB.[18]
Contrary to our expectation of higher HIV testing completion among people with TB
symptoms, we found that the presence of TB symptoms–defined by either cough of any dura-
tion, chronic cough, or any TB symptom–was not associated with HIV testing; in fact having
any TB symptom reduced posterior odds of completing HIV testing. Considering over 50% of
Table 2. Model posterior probabilities of completing HIV testing during clinic visit.
Posterior probability (mean odds ratio, 89% interval)
Parameter Model 1 Model 2a Model 2b Model 2c Model 3a Model 3b Model 3c Model 4a Model 4b Model 4c
Intercept 0.35 (0.25–
0.49)
0.28 (0.19–
0.42)
0.51 (0.26–
1.00)
0.06 (0.02–
0.16)
0.35 (0.25–
0.50)
0.62 (0.33–
1.18)
0.07 (0.03–
0.20)
0.42 (0.28–
0.62)
0.76 (0.39–
1.55)
0.09 (0.03–
0.24)
Male sex 1.15 (0.97–
1.37)
1.15 (0.96–
1.36)
1.16 (0.97–
1.39)
1.23 (1.01–
1.42)
1.16 (0.98–
1.39)
1.17 (0.99–
1.39)
1.24 (1.04–
1.49)
1.15 (0.97–
1.36)
1.17 (0.99–
1.38)
1.23 (1.05–
1.46)
Age (Per Year) 0.99 (0.98–
0.99)
0.98 (0.98–
0.99)
0.99 (0.98–
0.99)
0.99 (0.98–
0.99)
0.99 (0.98–
0.99)
0.99 (0.98–
0.99)
0.99 (0.98–
0.99)
0.98 (0.98–
0.99)
0.99 (0.98–
0.99)
0.99 (0.98–
0.99)
Previous TB 0.53 (0.29–
0.91)
0.50 (0.28–
0.84)
0.56 (0.31–
0.99)
0.52 (0.28–
0.90)
0.54 (0.31–
0.91)
0.50 (0.28–
0.86)
Ever Tested For
HIV
3.02 (2.10–
4.43)
2.96 (2.05–
4.46)
3.02 (2.07–
4.41)
Cough 1.21 (1.02–
1.44)
1.22 (1.03–
1.46)
1.24 (1.04–
1.47)
Chronic Cough 0.82 (0.59–
1.14)
0.84 (0.60–
1.17)
0.84 (0.58–
1.18)
Any TB
Symptom
0.90 (0.76–
1.06)
0.90 (0.75–
1.07)
0.88 (0.74–
1.05)
WAIC� 2196.0 2194.9 2193.6 2169.7 2197.3 2196.7 2173.2 2196.9 2195.7 2171.9
Weight 0.00 0.00 0.00 0.66 0.00 0.00 0.12 0.00 0.00 0.22
�WAIC = Watanabe-Akaike information criteria
https://doi.org/10.1371/journal.pone.0236407.t002
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clinic attenders in our study reported symptoms of TB, our findings suggest large numbers of
missed opportunities for new diagnoses of HIV and linkage to ART.
The Malawian Ministry of Health National Tuberculosis Control Programme recommends
PITC HIV testing for all patients with presumptive TB.[19] This issue is also recognised in the
Malawian National Strategic Plan for HIV AIDS 2015–2020 which suggests PITC HIV testing
should be moved upstream to include patients with suspected TB as well as confirmed TB;
however this is not listed as a priority intervention.[10] The findings in this study combined
with review of the literature suggest patients with TB symptoms should be list as a priority
intervention for expanding PITC, and further collaboration is needed between TB and HIV
coordinators at a national level.
With the maturation of the HIV epidemic in Southern Africa, the prevalence of HIV (and
undiagnosed HIV) is growing among older adults.[20] This key population, who often remain
sexually active, are challenging to reach with community-based HIV testing interventions.[21]
Our study shows facility rates of offering and acceptance of HIV testing decreased with
increasing age, again suggesting missed opportunities for HIV diagnoses. Efforts should be
made to incorporate HIV testing into guidelines for those with non-communicable diseases,
which are likely to be “unmasked” by this aging population. Men were more likely to test than
women which could be attributed to presenting later in their disease with more advanced clini-
cal symptoms and therefore triggering symptom-based PITC. Only 41.3% of patients who self-
Fig 2. Model posterior probabilities for completing HIV testing during clinic attendance for individuals with and without TB
symptoms.
https://doi.org/10.1371/journal.pone.0236407.g002
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reported having never previously tested were offered PITC. Utilising ROOT can help prevent
missing vital opportunities for this population to learn their status.
Participants with a self-reported history of HIV testing have previously undertaken pre and
post-test counselling and have overcome barriers of stigma relating to testing. This awareness
of the importance of knowing their status may drive them to request further HIV testing from
health-workers. This population of frequent HIV testers may also be undertaking higher risk
activities or presenting with conditions that demand frequent testing such as sexually transmit-
ted infections.
Our study does have limitations. Firstly due to limited availability of Research Assistants,
exit interviews were only performed in 44% of visits potentially resulting in bias in selection of
participants. It is possible that participants who were sicker were being referred to same day
secondary facilities and were under greater time-pressure and less likely to be stopped or
indeed engage with exit interview. Secondly symptoms and HIV testing patterns were self-
reported which could result in bias in measurement of outcomes. Thirdly patients were not
asked the time since last HIV test in exit interview. Therefore, an analysis of proportion of
patients testing annually in accordance with current WHO guidelines could not be performed.
Finally, results were taken from one health facility and may not be representative of findings
throughout the country and continent.
Conclusion
Same-visit completion of PITC in primary care was poorly implemented, especially among
groups known to have high prevalence of undiagnosed HIV (people with TB symptoms, older
adults). As countries approach universal coverage of ART, identifying and prioritising
Fig 3. Predicted probability of HIV testing by age and sex. Predicted probabilities are estimated from multivariable Bayesian regression models,
adjusted for no history of previous TB and not having tested previously for HIV.
https://doi.org/10.1371/journal.pone.0236407.g003
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currently underserved groups for HIV testing will be essential. Routine opt-out HIV testing
needs to be prioritised if HIV programmes are to identify and treat the missing millions with
undiagnosed HIV.
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